Therapeutics - 1 News by Insamo

Therapeutics - 1 News by Insamo

image description

Insamo launches with $12m funding to develop best-in-class membrane-permeable macrocyclic peptides

"Turn-key" solution from Insamo to revolutionise drug discovery

26-Feb-2024 - Insamo, a biotechnology company pioneering the discovery of membrane-permeable and orally available cyclic-peptides, announced $12 million in seed capital from Playground Global, venBio, and MRL Ventures Fund (MRLV). MRLV is a corporate venture arm of Merck & Co., Inc which invests in ...

therapeutics oral therapeutics artificial intelligence

These products might interest you

LPD_GPS_ Centrifugation Project

LPD_GPS_ Centrifugation Project by Thermo Fisher Scientific

Powerful at Every Turn – Meet the NEW General Purpose Centrifuge Family

The most versatile centrifuges designed to fit your application needs

centrifuges
View product
Thermo Scientific™ Heracell™ Vios™ CR CO2 Incubators CTS™ Series

Thermo Scientific™ Heracell™ Vios™ CR CO2 Incubators CTS™ Series by Thermo Fisher Scientific

Next-generation cleanroom confidence for cell therapy research and manufacturing

The first-to-market third party certified cleanroom-compatible CO2 incubator

cell culture incubators
View product
Show all therapeutics
Haven't found the right news yet?

The bionity.com news search

Start your targeted search now with a wide range of filter options. Our database includes an archive of 26,499 life science news from business and science, which you can search by topic and organization, filtered by time and geography.

Start news search now